TherapeuticsMD Files Q1 2025 10-Q
Ticker: TXMD · Form: 10-Q · Filed: May 13, 2025 · CIK: 25743
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financial-reporting
TL;DR
TXMD filed its Q1 2025 10-Q. All systems go.
AI Summary
TherapeuticsMD, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as AMHN, Inc., is incorporated in Nevada and operates in the pharmaceutical preparations sector. The filing details its financial status and business operations for the specified quarter.
Why It Matters
This filing provides investors and stakeholders with an update on TherapeuticsMD's financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing providing routine financial and operational updates.
Key Numbers
- 001-00100 — Commission File Number (Identifies the company's filing with the SEC)
- 87-0233535 — EIN (Employer Identification Number)
Key Players & Entities
- TherapeuticsMD, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- AMHN, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of TherapeuticsMD, Inc.?
TherapeuticsMD, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code 2834.
For what period is this 10-Q filing?
This 10-Q filing is for the quarterly period ended March 31, 2025.
In which state is TherapeuticsMD, Inc. incorporated?
TherapeuticsMD, Inc. is incorporated in Nevada.
What was TherapeuticsMD, Inc. formerly known as?
TherapeuticsMD, Inc. was formerly known as AMHN, Inc.
What is the SEC file number for TherapeuticsMD, Inc.?
The SEC file number for TherapeuticsMD, Inc. is 001-00100.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding TherapeuticsMD, Inc. (TXMD).